The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Taub Malcolm S since 2010.
The trader's CIK number is 1305117.
At the time of the last reporting, Taub Malcolm S was the Director of Brainstorm Cell Therapeutics Inc.. (stock ticker symbol BCLI).
Also see all insider trading activities at Brainstorm Cell Therapeutics Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2015 | BCLI | 0 | $0 | 55,222 | $145,577 | 0 | $0 |
| 2011 | BCLI | 0 | $0 | 774,991 | $250,509 | 0 | $0 |
| 2009 | BCLI | 0 | $0 | 575,000 | $147,025 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2015-12-14 | BCLI | Sale | 30,479 | 2.61 | 79,550 |
| 2015-12-15 | BCLI | Sale | 11,263 | 2.59 | 29,171 |
| 2015-12-10 | BCLI | Sale | 12,500 | 2.74 | 34,250 |
| 2015-12-11 | BCLI | Sale | 980 | 2.66 | 2,606 |
| 2011-07-08 | BCLI | Sale | 100,000 | .46 | 45,500 |
| 2011-06-06 | BCLI | Sale | 33,023 | .28 | 9,246 |
| 2011-05-17 | BCLI] | Sale | 61,400 | .30 | 18,420 |
| 2011-05-18 | BCLI] | Sale | 10,250 | .30 | 3,075 |
| 2011-04-12 | BCLI | Sale | 3,000 | .30 | 900 |
| 2011-04-13 | BCLI | Sale | 165,000 | .30 | 49,500 |
| 2011-04-07 | BCLI | Sale | 5,000 | .30 | 1,500 |
| 2011-04-04 | BCLI | Sale | 6,500 | .30 | 1,950 |
| 2011-04-05 | BCLI | Sale | 97,966 | .30 | 29,487 |
| 2011-04-01 | BCLI | Sale | 7,354 | .30 | 2,206 |
| 2011-03-31 | BCLI | Sale | 20,000 | .30 | 6,000 |
| 2011-03-22 | BCLI] | Sale | 43,630 | .30 | 13,089 |
| 2011-03-14 | BCLI] | Sale | 40,400 | .30 | 12,322 |
| 2011-03-10 | BCLI | Sale | 50,000 | .31 | 15,500 |
| 2011-03-08 | BCLI | Sale | 81,468 | .32 | 26,314 |
| 2011-03-09 | BCLI | Sale | 50,000 | .31 | 15,500 |
| 2009-09-14 | BCLI | Sale | 350,000 | .25 | 87,850 |
| 2009-09-15 | BCLI | Sale | 225,000 | .26 | 59,175 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Taub Malcolm S (Director of Brainstorm Cell Therapeutics Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.